FINWIRES · TerminalLIVE
FINWIRES

Kymera Therapeutics Shares Fall After Q1 Loss Narrows, Collaboration Revenue Rises

By

Kymera Therapeutics (KYMR) shares were down 3% in Thursday trading after it reported a Q1 loss of $0.71 per share, narrowing from a loss of $0.82 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.88.

Collaboration revenue for the quarter ended March 31 was $34.4 million, up from $22.1 million a year earlier.

Analysts polled by FactSet expected $8.3 million.

As of March 31, Kymera Therapeutics said it had $1.55 billion in cash, cash equivalents, and investments, which it expects to provide the company with a cash runway into 2029.

Price: $79.23, Change: $-2.28, Percent Change: -2.80%

Related Articles

Wire

Cheesecake Factory Q1 Adjusted Earnings, Revenue Rise; Shares Gain After Hours

Cheesecake Factory (CAKE) reported Q1 adjusted earnings late Wednesday of $1.05 per diluted share, up from $0.93 a year earlier.Analysts polled by FactSet expected $1.01.Revenue in the 13 weeks ended March 31 rose to $978.8 million from $927.2 million a year earlier.Analysts surveyed by FactSet expected $964.6 million.Cheesecake Factory shares rose 4.7% in after-hours trading.

$CAKE
Wire

Pilgrim's Pride Q1 Adjusted Earnings Fall, Sales Rise

Pilgrim's Pride (PPC) reported Q1 adjusted earnings late Wednesday of $0.51 per diluted share, down from $1.31 a year earlier.Analysts polled by FactSet expected $0.65.Net sales for the quarter ended March 29 rose to $4.53 billion from $4.46 billion a year earlier.Analysts surveyed by FactSet expected $4.43 billion.

$PPC
Wire

National Fuel Gas Fiscal Q2 Adjusted Earnings, Revenue Rise

National Fuel Gas (NFG) reported fiscal Q2 adjusted earnings late Wednesday of $2.71 per diluted share, up from $2.39 a year earlier.Analysts polled by FactSet expected $2.84.Revenue for the three months ended March 31 was $858.4 million, up from $730 million a year earlier.Analysts surveyed by FactSet expected $856.6 million.The company revised its fiscal 2026 adjusted EPS guidance range to $7.45 to $7.75 from $7.60 to $8.10 earlier. Analysts expect $7.79.

$NFG